Clinical Trial Update: Step 2 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating remimazolam besylate for sedation in ICU patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Care
• Mechanical Ventilation

Drugs mentioned

• Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Sedative, Mechanical Ventilation | Phase 3 | Status: COMPLETED